ABSTRACT
A Gamma-cyclodextrin-based clotrimazole nanogel for vaginal administration was developed with the primary intention of this study is to improve the solubility and dissolution profile of clotrimazole in vaginal fluid for the treatment of fungal infections. Gamma-cyclodextrin-based nanogel was made using the emulsion solvent evaporation method. Fluid stage was arranged utilizing γ-CD, NaOH, EGDE and HPMC (1 %,2% w/w). Natural stage was arranged utilizing Range 80(0, 0.5, 1, 2% w/v) in natural dissolvable dichloromethane. Watery stage was added to natural stage and homogenization was done trailed by lyophilization. An ultrasonic bath was used to treat the prepared solution. Utilizing a rotavapour, the water was evaporated. The gamma-cyclodextrin-clotrimazole complex had a glide score of – 2.85 kcal/mol, indicating the formation of a 2.4-kilogram hydrogen bond, according to Schrodinger molecular docking software. The phase solubility diagram revealed an AL type curve with a stability constant of 545 M-1, indicating the production of a 1:1 complex. F8 was picked as the ideal plan cluster. Batch F8 had a mucoadhesion force of 13.53g in grams. In the simulated vaginal fluid, Clotrimazole’s solubility in loaded nanogel increased by 15.45 times in comparison to that of pure Clotrimazole. At the finish of six hours, there had been a 79.67% medication discharge with a medication transition of 1.3596 g/cm2/h. The nanogel was made using the Korsmeyer-Peppas model, which has a r2 value of 0.9984. The final formulation displayed the standard zone of inhibition’s highest inhibition level.
Keywords: Gamma-cyclodextrin, EGDE, Clotrimazole, Nanogel.
INTRODUCTION
Among others, fungal diseases are responsible for the treatment of over 1 billion people and the deaths of over 1.5 million people annually. Antifungal is impacted if an accurate diagnosis is made early. Notwithstanding realizing that most passings from parasitic diseases are preventable, general wellbeing authorities keep on disregarding this issue. Numerous other health issues can result in serious fungal infections. Corticosteroid medications and organ transplants can be started immediately for asthmatics, AIDS patients, cancer patients, and others. Sadly, this is frequently not done or made available, leading to blindness, severe chronic illness, or death [1,2].
Nanogels certainly stand out as nanoscopic drug transporters, particularly for site-explicit or time-controlled organization of bioactive arbiters. The flexibility of polymer frameworks and the straightforwardness with which their physicochemical properties can be changed has come about in adaptable nanogel definitions. Nanogels offer extraordinary steadiness, drug stacking limit, biologic consistency, solid entrance capacity, and the capacity to answer natural boosts[3,4]. A few fields, including the delivery of genes, the administration of chemotherapeutic drugs, diagnostics, organ targeting, and many others, have shown that nanogels have great potential. Thenano-particulates drug conveyance framework offers a lot of benefits over customary measurement structures for instance decreased poisonousness, upgraded bio-dispersion and further developed patient compliance[5]. Unexpected flare-up in the area of nanotechnology have presented the requirement for creating nanogel frameworks which have demonstrated their capability to convey drugs in controlled, maintained and designated way. Due to its large surface area and nanosize range, cyclodextrin has been the polymer of choice for building nanosystems and nanogels. Cyclodextrin has greater advantages over cyclodextrin inclusion complexes due to its flexibility in altering behaviors, targeting, and API loading. This makes it now inevitable to prepare smart nano-systems that can prove effective for treatment as well as the progress of clinical trials [6,7]. Therefore, nanogel conveyance is more productive than conventional perceptible conveyance. A water-soluble nonionic polymer like hydroxypropylmethylcellulose or ethylcellulose is used to stabilize the nanogel dispersion [10]. Electrostatic, hydrophobic van der Waals interactions between the drug and the polymer matrix can cause phase separation of the drug-loaded nanogel, which can be hindered by dispersing the hydrophilic polymer. The scattered hydrophilic polymer opens to the skin surface by framing a defensive boundary that encompasses the nanogel, permitting the medication particles to stay scattered in the gel network [11]. Adjusted regular biopolymers with high happy practical gatherings and superfunctional cross linkers are utilized to make biopolymer-based nanogels. Compound cross-connecting, photopolymerization, synthetic based cross-connecting, and other creative procedures have all been taken on to accomplish self-gathering and cross-connecting of hydrophilic block copolymers. Block polymers are utilized between the inward and external layers of nanogels to control drug discharge from the polymer lattice [12,13]. The flexibility of these designs permits the joining of an extensive variety of visitor particles by suitably changing the materials utilized for development while keeping up with gel-like way of behaving, from inorganic nanoparticles to biopolymers like proteins and DNA. modified with a ligand to enable drug delivery via receptor at the site of action for cell- or target-specific drug delivery. Nanogels loaded up with drugs or natural specialists can conquer natural boundaries and delivery restorative specialists into cells. Nanogels have been widely used in biotechnology to address genetics, enzyme immobilization, and protein synthesis in recent years, proving to be a useful tool for the creation of new medical therapeutic systems [14].
Clotrimazole, an engineered imidazole subsidiary, is for the most part utilized locally to treat yeast and dermatophyte diseases of the vaginal and skin. It is effective against Candida species, Species of Trichophyton, Microsporum spp., and Pityrosporumorbiculare in vitro Malassezia furfur Additionally, it exhibits activity against Trichomonas spp. and some in vitro activity against Gram-positive bacteria. at extremely high levels.
Clotrimazole is an expansive range antifungal medication utilized fundamentally for the treatment of Candida albicans and different growths. A local treatment for athlete’s foot is called clotrimazole. It is an antifungal synthetic azole. Clotrimazole is a very much endured drug with not many incidental effects, however a few patients are hard-headed to treatment particularly those with immunodeficiency [15].
Clotrimazole is a lipophilic medication with a log k o/w of 4.1 and slow solvency in water. Microcapsules, liposomes, suspensions containing HPMC and nanospheres, cyclodextrin inclusion complexes, and solid dispersion techniques employing mannitol as a carrier have all been used in studies to enhance clotrimazole’s solubility. I am. Proceeding with this examination, we want to look into the impacts of water-solvent polymers [natural and synthetic] on the skin utilizing nanogel plans [16].
AUTHORIZED MATERIALS UTILIZED IN RESEARCH:ABSTRACT
Γ-cyclodextrin was purchased from ANALAB Fine Chemicals (Mumbai, India), hydroxypropylmethylcellulose was purchased from from LobaChemiePvt.Ltd (Mumbai, India), Span80, ethylene glycol diglycidyl ether, dichloromethane was purchased from TCI Chemicals Pvt.Ltd (India), clotrimazole was donated by Mylan Pharmaceuticals (Mumbai, India). All other compounds were of analytical quality and were used as such ANALAB Fine Chemicals (Mumbai, India) supplied cyclodextrin, LobaChemiePvt.Ltd (Mumbai, India) supplied hydroxypropyl methylcellulose, TCI Chemicals Pvt.Ltd (India) provides Span80, ethylene glycol diglycidyl ether, dichloromethane and Mylan Clotrimazole was donated by Pharmaceuticals (Mumbai, India) (Mumbai, India). The remaining substances were all of analytical grade and were used exclusively as they were.
PROCEDURAL APPROACH:
Cyclodextrin subsidiary determination
The clotrimazole-cyclodextrin derivative with the best fit was found using SchrodingerTM molecular docking software version 9.0. The best fit was resolved utilizing the float score and hydrogen holding boundaries. Based on a supramolecular synthon method that demonstrates the ability to form hydrogen bonds with clotrimazole, the cyclodextrin derivative was chosen. The PubChem database contained the structures of the following cyclodextrin derivatives: -cyclodextrin (CID: PubChem) -cyclodextrin (PubChem CID: 71597046), 2HP—cyclodextrin (PubChem CID: 444041), and 56972821). A low float score [Binding energy (kcal/mol)] was utilized to pick a cyclodextrin subordinate.
The solubility of pure CTZ in water and simulated vaginal fluid at various pH levels was investigated [17]. 0.2M NaOH and 0.2M HCL were utilized to modify the pH of the pre-arranged reproduced vaginal liquid and water. In a conelike jar, an overabundance of unadulterated prescription was acquainted with 10 mL of reenacted vaginal liquid and water with a pH scope of 3.5 to 7.5. The mixture was kept on a mechanical shaker (Remi, Mumbai, India) for 48 hours at 37°C and 80 rpm to make solubilization easier. The samples were kept at room temperature for 24 hours to reach equilibrium. Subsequent to sifting the material with a Whatman channel (0.45m), the filtrate was inspected utilizing a spectrophotometer (Jasco V-550, Japan). A similar interaction was utilized to research the dissolvability improvement of created CTZ nanogel at pH 3.5, 4.5, 5.5, 6.5, and 7.5 (Recreated vaginal liquid).
Clotrimazole phase solubility study in SVF:
Using the Higuchi and Corners method, a phase solubility analysis of CTZ was performed in the SVF medium. An excess of 200 milligrams of CTZ was added to an increasing concentration of gamma-cyclodextrin (-CD) in 10 milliliters of simulated vaginal fluid at a pH of 4.5. To work with solubilization, the blend was kept up with on a mechanical shaker (Remi, Mumbai, India) for 48 hours at 37°C and 80 rpm. To accomplish balance, the examples were held at room temperature for 24 hours. From that point forward, the example was sifted through a 0.45-m Whatman channel, and the filtrate was inspected with a spectrophotometer (Jasco V-550, Japan). Utilizing the Higuchi condition, the sort of incorporation intricate and the dependability steady (ks) were determined from the stage solvency outline.
ks=slope /So (1-slope)…………………….. (1)
Where ks is stability constant (M-1), So is the intrinsic solubility of CTZ. The slope is obtained from the linear line equation of the phase diagram.
FTIR investigation of the unadulterated clotrimazole, dried powder of the CTZ — – Cd incorporation mind boggling, dumped γ-Album nanogel, and clotrimazole stacked γ-Disc nanogel were completely exposed to FTIR examination. To get to the compliance of the medication in the complex and nanogel, 5mg of each example was burdened a scientific equilibrium (Mettler Toledo, H51, Switzerland) and put on the crystal of FTIR (QATAR-SIRSpirit), and the range was examined across a recurrence mid-IR region 400-4000cm-1.
Construction of nanogel
An emulsion-solvent evaporation method was used to create the nanogel, as will be discussed below
Composition of aqueous phase:
A 10 mL (20% w/w) solution of γ-CD in 0.2M NaOH was added to 4 mL of ethylene glycol diglycidyl ether (EGDE) after five minutes of agitation. In this 10 ml batch, HPMC solution in 0.2M NaOH (1 percent, 2% w/w) was added and heated for 25 minutes at 60°C.
Composition of organic phase:
Span 80 solutions (0, 0.5, 1, and 2% w/v) in the organic solvent dichloromethane make up the organic phase.
Composition of w/o emulsion:
14 milliliters of the aqueous phase and 20 milliliters of the organic phase were homogenized for eight minutes at 4000 rpm using an ultra-turra T 25 (Janke and Kunkel, Ink-Labortechnik, Germany). The emulsion was kept up with at 60°C for 30 minutes on an attractive stirrer (100 cycles each moment). The emulsions were quickly positioned into 100 mL of refined water and unsettled at 60°C for 3 hours to permit the dichloromethane to vanish totally and make a colloidal scattering.
Dialysis of nanogel scattering:
Each colloidal framework was isolated into 50 mL dialysis sacks (MWCO 12 — 14 KDa), which were in this manner put into water-filled measuring glasses. To eliminate pollutants, the water in the measuring utencils was revived like clockwork. Before being lyophilized (Operon, FDB-5503, Korea), the colloidal dispersion was kept at -40°C in a deep freezer to produce an unloaded γ -CD-nanogel powder.
Assessment of unloaded gamma CD nanogel:
Determination of percentage yield:
The practical yield of synthesized unloaded CD-nanogel for each batch was also calculated by adding the weights of γ-CD, HPMC, and EDGE (a cross-linker with a specific density of 1.114g/mL). A formula was utilized to compute the % yield of each clump of freeze-dried gamma-Compact disc nanogel.
Percentage yield = Practical yield/Theoretical yield * 100
Determination of particle size and polydispersity index:
The Malvern Zetasizer ZS 90 UK particle size analyzer was used to measure the PDI and particle size of freeze-dried unloaded nanogel. The freeze-dried nanogel powder was diluted with distilled water to evaluate the particle size and PDI [18].
Determination of swelling ratio:
The ratio of the prepared unloaded CD swelling nanogel was calculated [19,20]. About 0.2 g of unloaded CD nanogel was soaked in 100 mL of water for two hours, four hours, six hours, and eight hours, and then it was reweighed after filter paper was used to carefully remove any excess water. The formula below was used to calculate the unloaded CD-nanogel’s swelling ratio at each time point.
Differential Scanning Calorimetric studies of unloaded/loaded Gamma-CD-nanogel:
Differential scanning calorimetric (DSC) measurements were carried out using a thermal analyzer and a DSC-821 from Mettler Toledo DSC in Switzerland [21]. Unadulterated CTZ, HPMC, γ-Compact disc, dumped γ-Cd nanogel, and CTZ stacked γ-Cd nanogel (5 mg each) were precisely gauged and saved in fixed aluminum dish prior to being warmed under nitrogen stream (20 mL/min) at a checking pace of 10°C/min from 25 to 280° crushing a vacant aluminum skillet as a control.
Procedure of drug loading onto freeze dried gamma CD nanogel:
According to the results of the phase solubility investigation, CTZ:CD inclusion complex formation was stable at 1:1 molar ratio, and all freeze-dried nanogel batches were loaded with CTZ in 1:1 molar ratio, with the molecular weights of CTZ and γ-CD being
344.83 gm/mol and 1297 gm/mol, respectively. Clotrimazole acetone solution (10mL) was produced. For 60 minutes, the generated solution was treated in an ultrasonic bath at 25°C. The samples were processed in an ultrasonic bath at 25°C for 60 minutes after adding an aqueous solution of freeze-dried nanogel to the drug solution. Acetone was evaporated to make a gel with a Rota vapor R-210 and Vacuum Controller V-850 (Buchi, Switzerland)[22]
Assessment of CTZ-stacked gamma-CD nanogel Medication content and capture effectiveness:
The CTZ-stacked Disc drug nanogel content and capture proficiency were evaluated. 0.5 g of CTZ-stacked Disc nanogel was appropriately gauged and moved to a 100-ml funnel shaped carafe, trailed by 50 mL of HPLC-grade methanol and sonication for 10 minutes. Using a spectrophotometer (Jasco V-550, Japan), the following colloidal dispersion was filtered and analyzed to determine the CTZ concentration. The medication content and capture productivity were determined utilizing the condition beneath.
Assessment of particle size, polydispersity index (PDI), and zeta potential:
A molecule size analyzer (Malvern Zetasizer ZS 90, Worcestershire, UK) was utilized to decide the molecule size, PDI, and zeta capability of CTZ-stacked nanogel, as nitty gritty in the past segment of the methodology [23].
Enhanced formulation:
Drug content, entrapment efficiency, particle size, PDI, and zeta potential were used to select the best formulation, which was then tested for mucoadhesion force and drug release in SVF.
Mucoadhesion test:
A goat vaginal mucosal membrane from a slaughterhouse was used in a triplicate for the improved formulation’s mucoadhesion test. The membrane was kept in a simulated vaginal fluid with a pH of 4.5. The mucoadhesive power was estimated utilizing a Brookfield CT3 surface analyzer (produced in the USA) and a suitable test (g) [24].
Drug Transport:
The drug release of all of the nanogel batches that were made was tested using the Franz diffusion cell method (SES GmbH, Analyze System, Germany). A semi-permeable membrane with a diameter of 25 millimeters and a pore size of 0.45 millimeters was used to apply 2 grams of γ-CD nanogel to the glass fiber in the donor compartment. Reproduced vaginal liquid with a pH of 4.5 was placed in the receptor compartment. Around 0.5 mL of the material was removed at normal stretches for as long as 6 hours while the sink condition was kept up with. A spectrophotometer was used to evaluate the sample at a maximum wavelength of 280 nm. SVF was used to dilute each 0.5 mL of the sample to a total of 10 mL. A chart of total medication discharge versus time was made. The drug release of the improved batch F8 was compared to that of Carbopols.
Mathematical Modeling of drug release:
The drug release was mathematically modeled with the help of DDsolverTM [25,26,27]. The r2 (correlation coefficient), the AIC (Akaike information criterion), and the RMSE (root mean squared error) were utilized as selection factors to determine which model provided the most accurate representation of the dissolution data. Drug flow was also measured using the slope of the line equation created by plotting cumulative drug release against time (J).
Antifungal drug potency study:
The cup plate method was used to test the formulation’s efficacy as an antifungal drug. The National Collection of Industrial Microorganism, Pune, provided the fungus Candida albicans (NCIM No. 3674). The contagious culture was restored utilizing the streak plate procedure. The fungi were streaked on Sabouraud Dextrose medium containing 2% agar for the revive procedure, and they were allowed to grow for a day at 30°C. The developed culture was then filled the five sanitized Petri plates in aseptic condition and blended in with the 20 ml cleaned SDA media in every 4 petri plates. After hardening of the media, each petri plates were exhausted utilizing a cup drill to shape the wells. 2 wells were exhausted in each petri plate. The well received formulations as well. After 24 hours, the zone of inhibition was measured.
Study of vaginal permeation In-vivo:
Examination of in vivo vaginal penetration: Female Wistar rodents weighing 200-220 g were utilized in the investigation of in vivo vaginal penetration of the figured out detailing. The protocol was approved by the institution’s animal ethical committee in accordance with the strict guidelines set forth by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), which is part of the Ministry of Environment and Forest, Government of India. Every step of the animal handling procedure was performed by a trained individual. The rodents were housed in separation at a temperature of 25 °C with a 12-hour light/dim cycle and were given admittance to food and water voluntarily. Rats were divided into four groups. Six creatures were put in the principal bunch, which went about as the benchmark group and got no treatment. Real-time evaluation of vaginal permeability: The second group received CTZ dispersion, the third group received plain CTZ in situ gel, and the fourth group received CTZ-gamma-CD nanogel, with six rats in the control group and 18 in groups 2, 3, and 4. Before the experiment, rats’ vaginal smears were examined to determine the stage of the oestrus cycle. Only rats in the proestrus or estrus phase were used. The rats were starved for the entire night prior to the investigation. Six sub-gatherings of rodents from each gathering were made to analyze the medication’s vaginal pervasion over the course of time timespans, 2, 4, 8, and 48 hours. The rodent was held around the chest with its ventral surface looking up all through the organization of in situ gelling definitions. Using the soft plastic tip of a micropipette, a 0.1 ml dose of an in situ gelling formulation with a CTZ dose of 2.5 mg/Kg of body weight was gently injected into the vagina at a depth of 1 to 2 mm. The rat was kept in the same position for two to three minutes to ensure that the formulation turned into gel. Two rinses with sterile saline solution were administered to three animals from each group at the specified times to remove the gel from their vaginal cavities. The vagina was precisely isolated from the cervix and abs after the rodents were killed via carbon dioxide inward breath, and it was then removed. After being weighed, the vaginal tissue was cut with a cutter, cleaned with sterile saline, and wiped dry. The cut tissue was homogenized for 10 minutes at 8000 rpm with recently cooled dichloromethane (5 ml) in an ice shower to separate the drug. In a cooling centrifuge (Remi, CM-12 Plus, India), the mixture was centrifuged for ten minutes at 10,000 rpm. The vaginal tissue extract (0.5 ml) was infused with 50 g of amlodipine, and the solution was evaporated to dryness in a vacuum oven at 40 °C. A 60:40 combination of acetonitrile and 30 mM phosphate cushion (pH 4.0) in 1 ml of versatile stage was utilized to reconstitute the buildup prior to being vortexed and centrifuged. A formerly made and endorsed switch stage HPLC strategy was utilized to decide the medication content after the supernatant had been separated utilizing needle driven channels with a 0.22-m pore size. The HPLC quaternary gradient system (Lachrom 2000) was used, along with a Merck Hitachi L-7100 pump, a UV visible detector (L-7400), and a Neosphere C18 column (150 x 4.6 mm, 5.0 m). The linearity of CTZ was seen in a focus scope of 0.5 to 10 g/ml. Pharmacokinetic boundaries like the most extreme pinnacle centralization of the medication in tissue (Cmax) and the region under the tissue focus time bend (AUC 024) were resolved involving PK Solver programming in Microsoft Succeed. All results were introduced as mean and standard deviation values[28].
RESULTS:
Determination of Cyclodextrin subordinate:
Utilizing the SchrodingerTM molecular docking software, docking experiments for CTZ-γ-cyclodextrin, CTZ-β-cyclodextrin, and HP-β-cyclodextrin revealed bond lengths of 2.4, 2.12, and 0 kcal/mol as well as glide scores of -2.85 kcal/mol, -2.61 kcal/mol, and 0 kcal/mol, respectively. On the other hand, there was no interaction during docking experiments with HP-β-cyclodextrin. Due to its low glide score and bond length parameter, γ-cyclodextrin was chosen as the best match for clotrimazole.
For the unadulterated drug in water and reenacted vaginal liquid, pH dissolvability studies were directed at pH 3.5, 4.5, 5.5, 6.5, and 7.5. ( SVF). A similar exploration was finished in SVF with CTZ stacked nanogel. According to fig., the solubility of pure Clotrimazole in SVF was found to be between 0.5008 and 0.7858 mg/ml, while the solubility of Clotrimazole in water was found to be between 0.05207 and 0.01189 mg/ml at various pH levels. 2. SVF’s higher drug solubility compared to water may be due to the combination of alcohol, acids, and bovine serum albumin that it contains. The nanogel containing Clotrimazole had a solubility of 0.6931 to 1.4417 mg/ml. When compared to pure Clotrimazole, the solubility of the CTZ-loaded nanogel in water with a pH of 3.5 to 7.5 was 21.16, 15.45, 7.49, 6.07, and 16.63 times higher. n=3
Fig. 1: Solvency investigation of unadulterated Clotrimazole and CTZ stacked γ-Disc nanogel in different mediums at various pH conditions
Stage solvency study:
With γ-CD, a phase solubility study of CTZ was conducted in SVF. The curve of CTZ solubility as a function of increasing γ-CD concentrations is depicted in Figure 3. As can be seen, the solubility of CTZ rises in tandem with the concentration of γ-CD. A direct relationship is shown by a line condition with a r2 worth of 0.998. What’s more, the stage solvency chart showed an AL type bend, demonstrating the development of a 1:1 stoichiometric complex. The stability constant of 545 M-1 indicates a stable complex formation.
n=3
x-axis: Molar Gamma CD(mM/ml)
Y axis: Molar CTZ (mM/ml)
n=3
Fig. 2: Phase solubility diagram of CTZ with γ -CD in SVF (pH 4.5) at 370C
FTIR study:
The typical peaks of pure CTZ are depicted in Figure 4, which include C-N stretching at 1313.57 cm-1, C-H stretching at 756 cm-1, C=C stretching at 1633 cm-1, and N-H stretching at 1653 cm-1. Gamma CD frequencies were observed at 3271 cm-1, 2926 cm-1, 1019 cm-1, and 997 cm-1. The drug peak disappears at 1313 cm-1 in the lo aded nanogel, whereas there is no drug peak in the unloaded drug. This gave affirmation of FTIR study.
A- Pure CTZ drug
B- γ-CD
C- Unloaded nanogel
D- Loaded nanogel
Fig. 3: FTIR of pure CTZ, γ -CD, CTZ loaded γ -CD nanogel, unloaded γ -CD nanogel
Construction of freeze dried Nanogel :
Table 1 shows the equation for planning nanogel clumps. Different centralizations of HPMC and Length 80 were utilized to make nanogel bunches.
Table 1 : Γ-CD NANOGEL BATCHES PREPARATION
| γ -CD (%w/w) | HPMC(%w/w) | SPAN 80 (%w/v) | BATCH |
| 20 | 1 | 0 | F |
| 0.5 | F2 | ||
| 1 | F3 | ||
| 2 | F4 | ||
| 2 | 0 | F5 | |
| 0.5 | F6 | ||
| 1 | F7 | ||
| 2 | F8 |
Particle size, percentage yield, and PDI analysis of the unloaded nanogel:
The produced nanogel’s percentage yield, particle size, and PDI analysis are presented in Table 2. The yield went from 46.74 to 54.44 percent, with clump F1 having the least rate yield of 46.74 percent and bunch F8 having the best rate yield of 54.44percent. The findings indicate that as the concentrations of HPMC and Span 80 rise, so does the percentage yield of the nanogel.
Table 2: PERCENTAGE YIELD, PARTICLE SIZE, PDI ANALYSIS OF UNLOADED NANOGEL BATCHES
| Sr no. | Batch | Percentage yield | Particle size (nm) | PDI |
| 1 | F1 | 33(±0.097) | 323.71(±0.102) | 0.672(±0.04) |
| 2 | F2 | 36(±0.076) | 298.64(±2.01) | 0.544(±0.012) |
| 3 | F3 | 37(±0.055) | 263.01(±0.617) | 0.413(±0.032) |
| 4 | F4 | 39(±0.12) | 254.49(±0.974) | 0.330(±0.087) |
| 5 | F5 | 36(±0.10) | 311.8(±1.651) | 0.576(±0.036) |
| 6 | F6 | 39(±0.079) | 287.93(±0.0997) | 0.369(±0.097) |
| 7 | F7 | 40(±0.068) | 255.11(±1.03) | 0.437(±0.085) |
| 8 | F8 | 42(±0.094) | 211.6(±0.87) | 0.382(±0.053) |
n=3 (±SD)
Determination of swelling ratio:
The swelling ratios of various testing batches are shown in Table 3. Batches F4 and F8 contained the swelling ratios with the lowest values. This outcome may be attributed to the nanogel’s HPMC concentration. The ratio decreased as the amount of HPMC increased because HPMC prevents water from entering the unloaded -CD nanogel.
| Sr. no. | batch | 2 hours | 4 hours | 6 hours | 8 hours |
| 1 | F1 | 401(±1.019) | 438(±1.778) | 491(±0.811) | 510(±0.632) |
| 2 | F2 | 398(±1.401) | 415(±1.03) | 453(±0.452) | 460(±1.261) |
| 3 | F3 | 355(±0.702) | 380(±0.111) | 398(±0.234) | 488(±0.346) |
| 4 | F4 | 305(±1.504) | 360(±0.850) | 391(±0.121) | 475(±0.217) |
| 5 | F5 | 295(±0.665) | 355(±0.611) | 386(±1.042) | 445(±1.083) |
| 6 | F6 | 285(±0.750) | 365(±1.345) | 410(±0.623) | 435(±0.463) |
| 7 | F7 | 220(±1.021) | 350(±1.113) | 381(±0.327) | 415(±0.747) |
| 8 | F8 | 136(±1.171) | 254(±0.8) | 311(±0.785) | 388(±0.834) |
Table 3: SWELLING RATIO OF UNLOADED Γ-CD NANOGEL n=3
Differential Scanning Calorimetry Studies of Nanogel:
A DSC overlay of pure Clotrimazole, HPMC, γ-CD, unloaded γ-CD nanogel, and Clotrimazole-loaded γ-CD nanogel is depicted in Figure 5. Unadulterated CTZ has an articulated endothermic top at 147.05°C, which compares to the medication’s dissolving temperature of 148°C. The confirmation of drug trapping in the γ-CD cavity is the absence of this high endothermic peak in loaded nanogel.
Fig. 4: DSC overlay of Clotrimazole, HPMC, γ –CD, CTZ loaded γ -CD nanogel, unloaded – γ -CD
Evaluation of gamma-CD nanogels loaded with CTZ:
Drug content, entrapment efficiency, particle size, polydispersity index, and zeta potential of CTZ-loaded γ-CD Nanogel
The CTZ-loaded γ-CD nanogel’s drug concentration, entrapment efficiency, particle size, polydispersity index, and zeta potential are all shown in Table 4. It is evident that the drug content and entrapment efficiency increase with HPMC and Span 80 concentration. Cluster F8 had the most elevated (percent) drug content of 64.73 and the most noteworthy (percent) entanglement proficiency of 94.49 , though group F3 had the least (percent) drug content of 56.32 and the most reduced (percent) ensnarement productivity of 84.51. In contrast with Span80, HPMC plays a huge impact in supporting or bringing down drug content and entanglement proficiency. Batch F8 had the smallest particle size, 303 nm, with a PDI of 0.395 and a zeta potential of -6.05 mV. On the other hand, batch F1 had the largest particle size, 425 nm, with a PDI of 0.606 and a zeta potential of -13.8 mV. As the concentration of Span 80 increased, the particle size decreased because Span 80 acts as an stabilizer, by increasing zeta potential and reducing droplet size.
Table4 :% CTZ-LOADED NANOGEL’S DRUG CONTENTS, ENTRAPMENT EFFICIENCY, PARTICLE SIZE, PDI, and ZETA POTENTIAL
| Batch | (%)Drug content | (%) Entrapment efficiency | Particle size(nm) | PDI | Zeta potential (mV) |
| F1 | 56.69%(±0.036) | 84.51(±0.007) | 425(±0.577) | 0.606(±0.061) | -0.65(±0.002) |
| F2 | 61.47%(±0.290) | 92.86(±0.141) | 427(±1.577) | 0.418(±0.147) | -1.03(±0.009) |
| F3 | 56.32%(±0.399) | 87.17(±0.017) | 494(±0.513) | 0.292(±0.180) | -0.73(±0.004) |
| F4 | 64.14%(±0.490) | 93.01(±0.082) | 596(±0.923) | 0.360(±0.112) | -1.12(±0.0065) |
| F5 | 60% (±0.620) | 87.04% (±0.93) | 496(±1.311) | 0.207(±0.126) | -0.91(±0.0025) |
| F6 | 58.52%(±0.130) | 92.43%(±0.96) | 492(±1.216) | 0.301(±0.231) | -0.93(±0.0078) |
| F7 | 57.37% (±0.28) | 91.18(±0.0106) | 482(±1.058) | 0.276(±0.189) | -1.16(±0.006) |
| F8 | 64.73%(±0.273) | 94.49% (±0.007) | 303(±0.650) | 0.395(±0.125) | -1.33(±0.0031) |
n=3 (±SD)
Choice of enhanced batch:
Based on the particle size, PDI, zeta potential, (percent) drug content, and (percent) entrapment efficiency of CTZ-loaded -CD nanogel, Batch F8 was selected as the best batch for mucoadhesion and drug release..
Study of the drug release and mucoadhesion of adopted batch of nanogels:
The mucoadhesion of an optimized F8 batch ranged from 12.8 g to 14.9 g. Figure 6 portrays a plot of percent combined discharge versus time. The medication arrival of all clumps toward the finish of 6 hours changes, with cluster F8 delivering the most at 79.67 percent and group F1 delivering the least at 20.2 percent. This may be related to the nanogel’s particle size, which is influenced by the concentration of Span 80. (0% in F1 and 2 percent in F8 clump). It is evident that the concentration of HPMC and the concentration of Span 80 both have an impact on the drug release from the nanosized gel. The amount of drugs released increased.
Fig 65: Clotrimazole nanogel’s (%) Cumulative drug release in relation to time profile across all batches
The drug release of batches containing 2% HPMC was higher than that of nanogel batches containing 1% HPMC. A carbopol gel containing CTZ was compared to the F8 nanogel batch’s drug release. The carbopol gel batch produced fewer drugs than the F8 batch. The drug release mechanism was investigated through the use of mathematical modeling in accordance with the selection criteria (r2, AIC, RMSE) listed in table 5. Drug release from the polymeric system was predicted to follow the Korsmeyer-Peppas paradigm, according to the Korsmeyer-Peppas model. Furthermore, the fact that the first-order model performed second best suggests that drug release is influenced by concentration. AIC of 18.9194, RMSE of 1.2982, and r2 of 0.9984 were all found in the Korsmeyer-Peppas model. The medication motion was determined to be 1.3596 ug/cm2/h utilizing the slant of the direct piece.
Table 5: DRUG DELIVERY NUMERICAL MODELS OF BATCH F8
| MODEL | R2 | RMSE | AIC |
| Zero order | 0.8979 | 1.3603 | 18.8505 |
| First order | 0.9719 | 6.5709 | 40.8994 |
| Korsmeyer-Peppas model | 0.9984 | 1.2982 | 18.9194 |
| Hickson-Crowell | 0.9500 | 10.7955 | 47.8501 |
| Higuchi | 0.8652 | 4.9263 | 36.8667 |
Antifungal Potency Studies:
The Placebo-containing formulation had the smallest zone of inhibition compared to the standard ZOI, whereas the final formulation had the highest zone of inhibition. The observations suggest that the formulation is effective against fungi. The graphic depicts the antifungal efficacy test results. (Table 6)
| Sample | Zone of inhibition(mm) | %Zone of inhibition |
| Standard | 18 | 100 |
| Formulation | 17.3 | 96.11 |
| No drug | 1.9 | 10.55 |
TABLE-6
ANTIFUNGAL EFFICACY STUDY RESULTS
In vivo vaginal tissue take-up:
An in vivo vaginal tissue uptake study was carried out on Wistar rats in order to investigate the effect that the gamma-CD complex has on drug penetration in the vagina. The in vivo performance of CTZ-gamma-CD nanogel (VM1) and plain CTZ nanogel, which is administered intravaginally, is compared in Fig. 8. The reverse phase HPLC method was used to determine the CTZ penetrated per gram of vaginal tissue following a single dose of intravaginal formulations. The linearity for CTZ was tracked down over the reach, 0.5 to 10 µg/ml. At t=0, the CTZ concentration (C0) was 5.73 g/g for CTZ-gamma-CD nanogel, 4.22 g/g for plain CTZ nanogel, and 2.96 g/g for CTZ dispersion, respectively (Table 7). In 6 hours, the maximum concentration (Cmax) for CTZ dispersion was 3.54 g/g. The convergence of CTZ was past identification limit after 48 h. This could be because of expulsion of the scattering from the vagina because of its self-purifying activity. The CTZ plain nanogel arrived at greatest focus
(Cmax) in vagina (4.03 µg/g) in 6h. At the end of 48 hours, the concentration of CTZ decreased further, reaching 3.98 g/g. For the CTZ-gamma-CD gel, the maximum concentration, Cmax (11.13 g/g), was reached in four hours. The increased solubility of CTZ in the presence of gamma-CD and increased drug uptake by virtue of gamma-CD account for the faster CTZ penetration in gamma-CD gel. The total vaginal uptake of CTZ was 202.13 g.g1.h when administered as CTZ-gamma-CD nanogel and 181.80 g.g450 1.h when administered as CTZ nanogel, respectively.
Table 7: PHARMACOKINETIC PARAMETERS FOR VAGINAL DISTRIBUTION
| Vaginal Pharmacokinetic parameters | Carbopol gel with CTZ | CTZ loaded nanogel |
| Cmax | 4.03μg/g | 11.13μg/g |
| AUC0-24 | 181.87μg/g.h | 391.61μg/g.h |
Fig. 8: In vivo vaginal tissue uptake study
DISCUSSION:
As was mentioned earlier, cyclodextrin is a type of drug carrier that manipulates behavior, targets, and loads APIs to increase the solubility and extend the benefits of pharmaceuticals. Nonetheless, the right cyclodextrin determination should be finished to actually help the objective medication. An experimental scoring technique that comes near the ligand restricting free energy is known as the float score. It uses terms like “contributions to force fields” (electrostatic, van der Waals) and “rewarding or punishing interactions” that are known to affect ligand binding, among other things. Database enrichment, binding affinity prediction, and docking precision have all been improved. Since it mimics binding free energy, binders with a negative value are more tightly bound. Phase solubility tests also demonstrated that γ-cyclodextrin results in stable stoichiometric compound formation. Because the results with γ-cyclodextrin were quite good, it was chosen as the compound that best suited clotrimazole. To make a nanogel, copolymers were used to chemically cross-link γ-cyclodextrin. In this work, HPMC was picked as the polymer, and ethylene glycol diglycidyl ether (EGDE) filled in as the crosslinker. The -OH groups in the CD and HPMC react with the epoxide groups in the non-toxic cross-linker EGDE to form a complex that is strongly cross-linked in the presence of a mildly alkaline condition (0.2M NaOH) and a high temperature of 60°C. In the case of CD, -OH groups at C2 of the backbone linkage, -OH groups at C2 and C6 of the branch, and -OH groups at C2 and C6 of HPMC all react. FTIR and DSC studies confirmed that the medication was in the γ-CD cavity. The generated particle size of the nanogel was influenced by the concentration of Span 80. Droplet size, zeta potential, and particle size are all reduced as a result of Span 80’s role as an emulsifier and stabilizer. In order for a medication to be absorbed either locally or systemically through the vaginal mucosa, it must be solubilized in the fluid. Since there isn’t a lot of liquid accessible in the vaginal cavity, a medication like clotrimazole’s poor watery dissolvability is one of the difficulties that should be survived. Clotrimazole’s solubility in nanogel formulation increased in SVF in comparison to a pure drug. The drug’s increased solubility as a result of its nanosize and inclusion complex with cyclodextrin is to blame for this outcome.
The length of time a vaginal dose remains in the lumen is directly correlated with its effectiveness. Before the dosage form has a chance to work therapeutically, it is likely to leak or wash out. As indicated by drug discharge information, the medication will deliver at its pinnacle fixation six hours before any chance of disease emerges.
Compliance with ethical standards:
Conflict of interests: The authors declare that they have no conflict of interests.
Statement of Human and Animal Rights: Approval from Ethical Committee in accordance with “Principles of Laboratory Animal Care”.
Abbreviations:
BCS: Biopharmaceutical classification system; CTZ: Clotrimazole; γ-CD: Gamma-Cyclodextrin; DSC: Differential scanning calorimetry; r2: correlation coefficient; RMSE; Root-mean-square deviation; FTIR: Fourier-transform infrared spectroscopy; HPMC: Hydroxypropyl methylcellulose; EGDE: Ethylene glycol diglycidyl ether; SVF: Simulated vaginal fluid; API: Active pharmaceutical ingredient.
Authors Contribution: S.S.B,K.H., A.R.V, Y.J., K.K., K.P., L.T.S., P.K.E., A.P., D.S.P. and N.T. contributed toward data analysis, drafting, and revising the paper and agreed to be responsible for all the aspects of this work. All authors have read and agreed to the published version of the manuscript.
Data Availability Statement: The data sets generated and examined in this study can be obtained from the corresponding author upon a reasonable and justifiable request.
Ethical Approval Statement: This study adhered to all applicable ethical standards.
Conflict of Interest: The authors declare that there are no competing interests in this work.
Funding: No funding was received for this paper from any external source.
REFERENCES:
- Bongomin F, Gago S, Oladele RO, Denning DW. Global and multi-national prevalence of fungal diseases—estimate precision. Journal of Fungi .2017; 3:57
- Armstrong-James D, Meintjes G, Brown GD. A neglected epidemic: fungal infections in HIV/AIDS. Trends in Microbiology. 2014; 22:120-7.
- Neamtu L, Rusu AG, Diaconu A, Nita LE, Chiriac AP. Basic concepts and recent advances in nanogels as carriers for medical applications. Journal of Drug Delivery. 2017;24:539-57.
- Chacko RT, Ventura J, Zhuang J, Thayumanavan S.Polymer nanogels: a versatile nanoscopic drug delivery platform. Adv.Journal of Drug Delivery. Rev.2012;64:836-51.
- Patil A, Kontamwar P. Formulation and evaluation of antifungal nanogel for topical drug delivery system. Asian Journal of Pharmaceutical and Clinical Research.2021 ;14:127-134.
- Dorwal D. Nanogels as novel and versatile pharmaceutical. International Journal of Pharmacy and Pharmaceutical Sciences.2012;4:67-74.
- Sultana F, Imran-Ul-Haque M, Arafat M, Sharmin S. An overview of nanogel drug delivery system. Journal of Applied Pharmaceutical Sciences. 2013;3:S95-105.
- Labhasetwar V, Diandra L, Leslie Pelecky, Yallapu M M. Nanogels: chemistry to drug delivery .Wiley,2007.
- Johannesson G, Stefansson E, Loftsson T. Microspheres and nanotechnology for drug delivery. Developments in Ophthalmology. 2015; 55:93–103.
- Hoare T, Sivakumaran D, Stefanescu CF, Lawlor MW, Kohane DS. Nanogel scavengers for drugs: Local anesthetic uptake by thermo responsive nanogels. Acta biomaterialia.2012; 8:1450-8.
- Ramos J, Imaz A, Forcada J.Temperature-sensitive nanogels: poly (N-vinylcaprolactam) versus poly (N- isopropylacrylamide). Polymer Chemistry. 2012;3:852-6.
- Molinos M,Carvalho V, Silva DM, Gama FM. Development of a hybrid dextrin hydrogel encapsulating dextrin nanogel as protein delivery system. Biomacromolecules.2012;13:517-27.
- Schmitt F, Lagopoulos L, Käuper P, et al. Chitosan-based nanogels for selective delivery of photosensitizers to macrophages and improved retention in and therapy of articular joints. Journal of Controlled Release. 2010; 144:242-50.
- Ghaywat SD, Mate PS, Parsutkar YM, Chandimeshram AD, Umekar MJ. Overview of nanogel and its applications. GSC Biological and Pharmaceutical Sciences.2021;16:040–061
- Crowley PD, Gallagher HC. Clotrimazole as a pharmaceutical: past, present and future. Journal of Applied Microbiology.2014 ;117:611-7.
- Balata G, Mahdi M, Bakera RA. Improvement of solubility and dissolution properties of clotrimazole by solid dispersions and inclusion complexes. Indian Journal of Pharmaceutical Sciences. 2011;73:517.
- Marques M, Loebenberg R, Almukainzi M. Simulated biological fluids with possible application in dissolution testing. Dissolution Technology. 2011;18:15-28.
- Imperiale JC, Bevilacqua G, De Rosa PTV et al. Production of pure indinavir free base nanoparticles by a supercritical anti- solvent (SAS) method. Drug Development and Industrial Pharmacy.2014;40:1607–1615.
- Wong R, Ashton M, DodouK. Effect of cross-linking agent concentration on the properties of un-medicated hydrogels. Pharmaceutics. 2015; 7: 305-319.
- Malik N, Ahmad M. MinhasM.Cross-linked β-cyclodextrin and carboxymethyl cellulose hydrogels for controlled drug delivery of acyclovir. PloS one.2017; 12: 0172727.
- Mohanraj VJ, Chen Y . Nanoparticles – A review. Trop J Pharm Res.2007;5:61—73.
- Manchun S, Dass C, Sriamornsak P. Stability of freeze-dried pH-responsive dextrin nanogels containing doxorubicin. Asian Journal of Pharmaceutical Sciences.2016; 11:648-654.
- Yao Y, Xia M, Wang H, Li G, Shen H, Ji G et al. Preparation and evaluation of chitosan-based nanogels/gels for oral delivery of myricetin. Eur Journal of Pharmaceutical Sciences.2016; 91: 144-153.
- Rençber S, Karavana S, Şenyiğit Z, Eraç B, Limoncu M, Baloğlu E. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation. Pharmaceutical Development and Technology.2016;22:551-561.
- Mennini N, Casella G, Cirri M, Maestrelli F, Mura P.Development of cyclodextrin hydrogels for vaginal delivery of dehydroepiandrosterone. Journal of Pharmacy and Pharmacology.2016;68: 762-771.
- He L, Liang H, Lin L, Shah BR, Li Y, Chen Y, Li B. Green-step assembly of low density lipoprotein/sodium carboxymethyl cellulose nanogels for facile loading and pH-dependent release of doxorubicin. Colloids and Surfaces B .2015; 126:288- 96.
- Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, XieS. DDSolver: An Add-In program for modeling and comparison of drug dissolution profiles. The AAPS Journal.2010; 12:263-271.
- Deshkar SS, Palve VK. Formulation and development of thermosensitive cyclodextrin-based in situ gel of voriconazole for vaginal delivery.Journal of Drug Delivery Science and Technology. 2019;49:277-85.
